Abstract

Biomarkers are Novel and Revered Tools and Technologies (NORETs) which have helped previous studies anticipate diverse disease conditions and complications as well as provide similarly close prognosis for them. These NORETs in rare but common studies regarding Type 2 Diabetes (T2D) has helped health care professionals and scientists identify health-worthy indications relating to T2D complications and potential risk factors. Biomarkers in its own way debuting in the diagnosis and prognosis of T2D has provided health care professionals with the basic kits of understanding how these diseases manifest from seemingly mild problems which we often times ignore to complicated problems, also indicating possible causes. In this study, the pathophysiology of T2D was subtly exhausted pointing the focus towards the rapidly modifying metabolic manifestations of T2D as well as its risk complications. This study thus reveals the on-going advancement of biomarkers in fully understanding, identifying, diagnosing and treating T2D

Highlights

  • Diabetes in both developed and developing countries of the world has resulted in severe complications like high blood pressure, cardiovascular complications, renal dysfunction, visual malfunctioning, and even blindness

  • Several countries have participated in the biomarker revolution in expressly every biological assay. We discovered from these sole benefactors of the advances of biomarkers in the early ages of research development had noted that the sweet taste, which was raw and concentrated indicated the presence of excessive sugar which in turn contributed to the basis for diabetes test using urine

  • Digressing a little, we find that in Perera and Weinstein’s and Naylor’s studies that as complex and complicated the nervous system is and has been in recent times, the wider and more advanced the NORETS utilized in assessing the information about the Nervous boxthe brain and related disease complications [16,17]

Read more

Summary

Introduction

Diabetes in both developed and developing countries of the world has resulted in severe complications like high blood pressure, cardiovascular complications, renal dysfunction, visual malfunctioning, and even blindness. Studies like those of Yang et al [9] and Barazzoni et al [10] have provided researchers with potential biomarkers (ghrelin and retinol-binding protein) to work with, yet, Echouffo-Tcheugui et al [11] could rarely see through the loop into T2D risk complications It would be an outstanding relief when substantial biological tools in the prediction of T2D and risk complications as well as its relatives are identified. The biomarker in its tailored parametric (chemical, physical and biological) capacity can independently assess the growth and development of the disease, likewise the receptive effects of the administered management With these whelming explanations made easy, biomarkers are any kind of indicator that gives an accurate or near accurate diagnosis of certain physiologic problems and in this study, T2D

Characteristics of Biomarkers
Biomarkers Requisite
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call